SpineGuide Technologies
SpineGuide Technologies is developing a revolutionary implant system to treat both Early Onset Scoliosis and Adolescent Idiopathic Scoliosis.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Shoreview, MN 55126, USA
- Currency USD
- Founded November 2018
- Employees 7
- Incorporation Type C-corp
- Website spineguidetechnologies.com
Company Summary
REVOLUTIONARY next generation technology for scoliosis:
1.$1B+ USD Target market: 1st solution for both AIS and EOS
2.First in human trial: self funded first in human trial in China expected in Q1 2021
3.Significant clinical value: correct curvature effectively, likely no traumatic final fusion; enable growth 100% noninvasively
4.EOS competitor Ellipse (MAGEC) acquired by Nuvasive for $410M USD in 2016
Team
-
Founder and CEODr. Li is the Associate Clinical Professor Orthopaedic Department of 2nd Hospital of Shanxi Medical University, an orthopedic surgeon of 15 years. He oversees the development and manufacturing of CurvRITE.
He was a research associate at Brown University and visiting scholar at Orthopaedic Department of Children's hospital of Los Angeles. His research comprises over 10 published papers. He holds over 8 US and foreign patents with 4 pending. -
Chief Regulatory/Clinical Trial OfficerJohn has extensive experience in the strategy, design, analysis, and reporting of clinical trials and programs to support early product feasibility, product approval and post-marketing requirements around the world. He has worked over 17 years in pharmaceutical, medical device and IVD industries with strong and diverse therapeutic background. He managed a global team of experienced consultants to support global medical product development.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.